Combined Occurrence of Autosomal Dominant Aniridia and Autosomal Recessive Albinism in Several Members of a Family

被引:12
|
作者
Yahalom, Claudia [1 ,2 ]
Sharon, Dror [1 ]
Dalia, Eli [2 ]
Ben Simhon, Shiran [1 ]
Shemesh, Efrat [1 ]
Blumenfeld, Anat [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Michaelson Inst Rehabil Vis, Jerusalem, Israel
关键词
Albinism; aniridia; genetics; OCULOCUTANEOUS ALBINISM; TYROSINASE GENE; MUTATIONS;
D O I
10.3109/13816810.2015.1005318
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: To characterize clinical and genetic aspects of a family with a unique combination of two hereditary blinding eye diseases. Methods: Comprehensive eye examination of proband and family members. Molecular analyses of the TYR and PAX6 genes. Results: A young couple, both legally blind, requested genetic counselling regarding their ocular condition. The female was previously diagnosed with oculocutaneous albinism (OCA1A) and her spouse was diagnosed with Peters anomaly. A comprehensive clinical examination revealed that the female had OCA1A combined with signs of another ocular disease, showing some similarity to aniridia. A complete ocular examination of her family members revealed that her brother also suffered from the same combined phenotype, her father had typical OCA1A signs, and her mother and sister had aniridia-like phenotype, without clinical diagnosis until the time of presentation. Molecular analysis identified two compound heterozygous TYR mutations known to cause OCAIA and cosegregate with oculocutaneous albinism. In addition, we identified a novel heterozygous PAX6 mutation confirming the atypical aniridia phenotype. Conclusions: We report here a unique and rare clinical phenotype that is explained by the segregation of two severe inherited eye diseases. The clinical and genetic analysis in this family allowed them to receive accurate genetic counseling.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [41] Rare Genetic Causes of Autosomal Dominant or Recessive Hypercholesterolaemia
    Soutar, Anne K.
    IUBMB LIFE, 2010, 62 (02) : 125 - 131
  • [42] Autosomal dominant proximal renal tubular acidosis at seven members of one family
    Savenkova, N.
    Anichkova, I.
    Leviashvili, G.
    Chemodanova, M.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1637 - 1637
  • [43] X-LINKED RECESSIVE ICHTHYOSIS AND AUTOSOMAL DOMINANT ICHTHYOSIS SEGREGATING IN THE SAME FAMILY
    TRAUPE, H
    HAPPLE, R
    ROPERS, HH
    MULLER, CR
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1981, 271 (02) : 149 - 156
  • [44] Birth Prevalence and Mutation Spectrum in Danish Patients with Autosomal Recessive Albinism
    Gronskov, Karen
    Ek, Jakob
    Sand, Annie
    Scheller, Rudolf
    Bygum, Anette
    Brixen, Kim
    Brondum-Nielsen, Karen
    Rosenberg, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (03) : 1058 - 1064
  • [45] A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients
    Hutton, Saunie M.
    Spritz, Richard A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (03) : 868 - 872
  • [46] A FAMILY WITH AN AUTOSOMAL-DOMINANT MEGALENCEPHALY
    STROY, JPM
    GABREELS, FJM
    RENIER, WO
    COLON, E
    NEUROPEDIATRICS, 1983, 14 (02) : 124 - 124
  • [47] AUTOSOMAL DOMINANT ARTHROPATHY IN A FRENCH FAMILY
    GAUCHER, A
    WERYHA, G
    PERRIER, P
    MOREAU, P
    PERE, P
    GILLET, P
    VU, VD
    ARTHRITIS AND RHEUMATISM, 1991, 34 (06): : 737 - 743
  • [48] Melorheostosis in a family with autosomal dominant osteopoikilosis
    Nevin, NC
    Thomas, PS
    Davis, RI
    Cowie, GH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 82 (05): : 409 - 414
  • [49] AUTOSOMAL DOMINANT OSTEOPETROSIS - A FAMILY STUDY
    BOLLERSLEV, J
    GRODUM, E
    GRONTVED, A
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1987, 101 (10): : 1088 - 1091
  • [50] Autosomal Recessive Transmission of Psychosis in a Consanguineous Family
    Pardo, Jose
    Sheikh, Sohail
    Aslam, Faiza
    Yaseen, Samina
    Naz, Sadaf
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 182 - 182